This image is a representation. Your design will be featured in the final product.

Warning: The information provided on this page is for general knowledge purposes only and does not replace the official Instructions for Use (IFU), which are supplied with the medical device. This page does not constitute an electronic IFU either. 

Allerspray: medical device for the treatment of allergic rhinitis


ALLERSPRAY is a  medical device  specifically designed to form an osmotic, stable, and non-irritating barrier against environmental allergens and contaminants. 

This unique formulation includes a blend of plant-based ingredients ensuring a high-quality product that is both effective and safe for use.

For Children: Available in two formulas – Code AE and Code AEE


Clinical trial

Randomized, double-blind, placebo-controlled trial

Population

This product is intended for adult use

Indication

Used in adults for the symptomatic treatment of seasonal and intermitent mild-to-moderate allergic rhinitis.

Patient's benefits ​Clinical studyProduct DetailsNeed more information

Patient's benefits ​

  • Protective barrier effect against allergens
  • Reduction of nasal symptoms such as nasal congestion, sneezing, nasal irritation andrhinorrhea within 7 days
  • Reduced eye symptoms such as redness, tearing and burning within 7 days
  • Improvement in quality of life from the reduction of both nasal and ocular symptoms
  • Reduced need for allergic rhinitis medication medication 
  • Prevent secondary infection and progression to a severe, chronic form 
  • Improved patient well-being and sleep quality

Mode of Action

  • Protective Barrier: Establishes a filmogenic shield on the nasal mucosa, preventing irritants from triggering allergic reactions.
  • Mechanical Cleaning: Utilizes osmotic activity to remove contaminants, reducing inflammation and symptoms.
  • Cellular Repair: Promotes healing and regeneration of the nasal mucosa for sustained relief.

Clinical study


A randomized, double-blind clinical trial (n = 51) confirmed the effectiveness of the product in relieving allergic rhinitis symptoms over 3 weeks.

It led to a 73% reduction in total nasal symptoms and a 64% reduction in ocular symptoms, with improvements starting from the first week. The RQLQ score improved by 50%, indicating a clear enhancement in quality of life.

The need for rescue medication was significantly lower in the test group (29% vs 80%), and allergic activity dropped by 68%, along with a marked reduction in eosinophil count.

These results highlight the product’s strong anti-allergic effect and excellent clinical benefit in managing nasal and ocular allergy symptoms.

Product Details


  • Indication: Used in adults for the symptomatic treatment of seasonal and intermitent mild-to-moderate allergic rhinitis.
  • Composition: Made from plant-based ingredients
  • Presentation: 15ml nasal spray
  • Class: MDR Class IIa.
  • Age: Suitable for adults 18 and over.
  • Storage: Store below 25°C.
  • Manufacturer: VITROBIO, France.
  • Product Code: AAG.


Need more information